Remdantry
infliximab for injection, sterile lyophilized powder for solution, for intravenous infusion; 100 mg/vial, Celltrion Healthcare Canada.
INDICATIONS Indicated for use in adults with moderately to severely active rheumatoid arthritis, active ankylosing spondylitis, adults and children with moderately to severely active Crohn’s disease, adults with fistulising Crohn’s disease, adults and children with moderately to severely active ulcerative colitis, psoriatic arthritis, and adults with chronic moderate to severe plaque psoriasis; consult product monograph for details.
DOSAGE Varies according to indication; consult product monograph for details.
COMMENTS Biosimilar to Remicade. Product name change (formerly known as Inflectra).
COVERAGE A benefit under Pharmacare formulary!
